Landmark Advances in High Risk Acute Coronary Syndrome WebCAST

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

December 15, 2008

Expiration Date:

December 15, 2010

Intended Audience:

• Emergency medicine specialists
• Emergency medicine physicians-in-training
• Emergency medicine fellows
• Emergency medicine nurse
• Nurse practitioners (NPs) with EM concentration
• Emergency medicine investiga tors and clinical scholars
• Emergency medicine program directors
• Emergency medicine residency program di rectors
• Physician assistants (PAs) with emergency medicine focus
• Emergency medicine technicians (EMTs) and paramedics at all levels
• Prehospital care providers
• Cardiologists and cardiovascular specialists
• Critical care physicians and intensivists

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent
educational grant from
The Medicines Company.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Charles V. Pollack Jr, MA, MD, FACEP, FAAEM
Grant/Research Support: GSK, sanofi-aventis
Consultant: sanofi-aventis, Schering-Plough, The Medicines Company
Speaker’s Bureau: sanofi-aventis, Schering-Plough

Sunil V. Rao, MD, FACC
Grant/Research Support: Cordis
Consultant: sanofi-aventis, The Medicines Company
Speaker’s Bureau: sanofi-aventis, Cordis, The Medicines Company

Gregory Volturo, MD, FACEP
Consultant: Ortho-McNeil

Gary Schaer, MD, FACC
Grant/Research Support: The Medicines Company, sanofi-aventis
Consultant: sanofi-aventis, BMS
Speaker’s Bureau: The Medicines Company, sanofi-aventis, Schering-Plough

Program Faculty:

Program Chairman
Charles V. Pollack Jr, MA, MD, FACEP, FAAEM
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Professor of Emergency Medicine
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Sunil Rao, MD, FACC
Director of Interventional Cardiology
Veterans Administration Medical Center
Assistant Professor
Division of Cardiovascular Medicine
Duke University Medical Center
Durham, North Carolina

Gary Schaer, MD, FACC
Professor of Medicine
Director, Cardiac Catheterization Laboratory
Rush Medical College
Rush Presbyterian Medical Center
Chicago, Illinois

Gregory Volturo, MD, FACEP
Chairman and Professor
Department of Emergency Medicine
University of Massachusetts Medical School
Worcester, Massachusetts

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn to apply evidence from recent landmark trials and national guide lines to new practice paradigms for managing STEMI and high risk ACS.
• Learn to identify signs, symptoms, and prognostic features of high risk ACS and STEMI.
• Learn to assess and implement optimal pharmacologic interventions consistent with the latest evidence and national guidelines.
• Learn to characterize, identify, and evaluate the safety, efficacy, and side effects of myriad therapeutic options used for STEMI and high risk ACS, including, aspirin, antiplatelet agents, direct thrombin inhibitors, UFH, LMWHs, and factor Xa inhibitors.
• Learn to understand the specific advantages and potential disadvan tages of currently pharmacologic agents used to reduce ischemic and bleeding end points in the setting of cardiovascular emergencies.
• Learn to discuss and assess the impact that new trials and AHA/ACC Guidelines are likely to have on future management of patients with STEMI and high risk ACS.
  

Disclaimer:

Copyright © 2008 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved